BlossomHill Therapeutics, Inc. (BLSM) vs Crescent Biopharma, Inc. (CBIO)
A side-by-side comparison of BlossomHill Therapeutics, Inc. and Crescent Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLSM
BlossomHill Therapeutics, Inc.
$19.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CBIO
Crescent Biopharma, Inc.
$13.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BLSM vs CBIO
growth of $100 · dividends reinvested · last 1yBLSM +24.6% (+24.6%/yr)CBIO -15.2% (-15.2%/yr)BLSM compounded faster over this window
BLSM CBIO
BLSM vs CBIO: by the numbers
- •BLSM is the larger company ($580M vs $518M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -1371.51% net margin).
Metrics side by side
Valuation
| Metric | BLSM | CBIO |
|---|---|---|
| P/S ratio | N/A | 43.57 |
| P/B ratio | N/A | 3.25 |
Profitability
| Metric | BLSM | CBIO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -1407.52% |
| Net margin | 0.00% | -1371.51% |
| ROE | N/A | -99.83% |
| ROIC | -43.41% | -102.59% |
Growth (annualized)
| Metric | BLSM | CBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 39.89% |
| Total return CAGR (5Y) | N/A | -24.40% |
Go deeper
Dig into the metrics
BlossomHill Therapeutics ROECrescent Biopharma ROEBlossomHill Therapeutics operating marginCrescent Biopharma operating marginBlossomHill Therapeutics revenue growthCrescent Biopharma revenue growthBlossomHill Therapeutics free cash flowCrescent Biopharma free cash flow
BlossomHill Therapeutics & Crescent Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.